Evoke Pharma, Inc (EVOK)

Etorro trading 970x250
Evoke Pharma, Inc (EVOK) Logo

About Evoke Pharma, Inc

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. Address: 420 Stevens Avenue, Solana Beach, CA, United States, 92075

Evoke Pharma, Inc News and around…

Latest news about Evoke Pharma, Inc (EVOK) common stock and company :

Patient Experience Survey Reported Positive Findings for GIMOTI®
18 May, 2022 Yahoo! Finance

Research Study Among Patients Demonstrated Favorable Acceptance and Utilization of GIMOTISOLANA BEACH, Calif. and CHICAGO, May 18, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, a leading provider of global commercial services to the life science industry, today announced positive findings from the first patient-centered survey related to GIMOTI. Following the series of market

Evoke Pharma to Present at H.C. Wainwright Global Investment Conference
17 May, 2022 Yahoo! Finance

SOLANA BEACH, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal spray, today announced that its management team will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022. The presentation will be virtual and will provide an overview of the comm

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
17 May, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It's time for another busy day of trading as we dive into the biggest pre-market stock movers for Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

24 Stocks Moving in Tuesday's Pre-Market Session
17 May, 2022 FinancialContent

Gainers Bird Global, Inc. (NASDAQ: BRDS) rose 26.3% to $1.24 in pre-market trading after the company posted strong Q1 ...

12 Health Care Stocks Moving In Friday's After-Market Session
13 May, 2022 FinancialContent

Gainers Trevena (NASDAQ:TRVN) shares moved upwards by 13.3% to $0.23 during Friday's after-market session. The market value of their ...

Evoke Pharma: Q1 Earnings Insights
10 May, 2022 FinancialContent

Evoke Pharma (NASDAQ:EVOK) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM. Here's what investors need to know ...

Evoke Pharma Reports First Quarter 2022 Financial Results
10 May, 2022 Yahoo! Finance

Several sales growth indicators increased over Q4, 2021: New Prescribers up 41%; Product delivered to patients up 39%; Net Revenue increased by 16%; Prescriptions written up 22%SOLANA BEACH, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the first quarter ended March 31, 2022, and recent corporate developments. “We are encou

Evoke Pharma to Report First Quarter 2022 Financial Results on May 10, 2022
03 May, 2022 Yahoo! Finance

SOLANA BEACH, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company is scheduled to release its first quarter 2022 financial results on Tuesday, May 10, 2022, after the market closes. Management will host a conference call on Tuesday May 10, 2022, at 4:30 p.m. ET to discuss the results. The dial-in numbers for the conference call are (800) 891-3840 f

20 Stocks Moving in Monday's Pre-Market Session
02 May, 2022 FinancialContent

Gainers SoundHound AI, Inc. (NASDAQ: SOUN) rose 64.3% to $10.68 in pre-market trading after tumbling 13% on Friday. SoundHound had ...

70 Biggest Movers From Friday
02 May, 2022 FinancialContent

Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired ...

48 Stocks Moving In Friday's Mid-Day Session
29 Apr, 2022 FinancialContent

Gainers Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
29 Apr, 2022 FinancialContent

Gainers Finch Therapeutics Group (NASDAQ:FNCH) stock increased by 55.7% to $3.27 during Friday's pre-market session. ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
29 Apr, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It's the beginning of the end as we break down all of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

28 Stocks Moving in Friday's Pre-Market Session
29 Apr, 2022 FinancialContent

Gainers Zymeworks Inc. (NASDAQ: ZYME) rose 40.3% to $6.97 in pre-market trading. Zymeworks 13D filing confirmed earlier reporting ...

74 Biggest Movers From Yesterday
29 Apr, 2022 FinancialContent

Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its ...

12 Health Care Stocks Moving In Thursday's Intraday Session
28 Apr, 2022 FinancialContent

Gainers Statera BioPharma (NASDAQ:STAB) stock moved upwards by 119.1% to $0.46 during Thursday's regular session. As ...

61 Biggest Movers From Yesterday
28 Apr, 2022 FinancialContent

Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
27 Apr, 2022 FinancialContent

Gainers Cosmos Holdings (NASDAQ:COSM) shares rose 68.6% to $1.79 during Wednesday's regular session. Cosmos ...

38 Stocks Moving In Wednesday's Mid-Day Session
27 Apr, 2022 FinancialContent

Gainers Vivakor, Inc. (NASDAQ: VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with ...

20 Stocks Moving in Wednesday's Pre-Market Session
27 Apr, 2022 FinancialContent

Gainers Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 100.9% to $2.13 in pre-market trading after jumping over 16% on Tuesday. ...

71 Biggest Movers From Yesterday
27 Apr, 2022 FinancialContent

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product ...

Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Protagonist Therapeutics Shares Plummet
26 Apr, 2022 FinancialContent

U.S. stocks remained lower toward the end of trading, with the Dow Jones tumbling more than 500 points on Tuesday. The Dow traded ...

Why Is Evoke Pharma (EVOK) Stock Up 130% Today?
26 Apr, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evoke Pharma is up an unbelievable 130% today on news of recently granted drug exclusivity. How high will EVOK stock soar? The post Why Is Evoke Pharma (EVOK) Stock Up 130% Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

12 Health Care Stocks Moving In Tuesday's Intraday Session
26 Apr, 2022 FinancialContent

Gainers Evoke Pharma (NASDAQ:EVOK) stock moved upwards by 138.5% to $0.94 during Tuesday's regular session. As of ...

Warner Bros. Discovery adds 2 million subscribers in first earnings report
26 Apr, 2022 Yahoo! Finance

Yahoo Finance's Ines Ferre joins the Live show to break down how stocks are moving in midday trading.

Evoke Shares Skyrocket On New FDA Market Exclusivity For Gimoti Nasal Spray
26 Apr, 2022 FinancialContent

TheFDA has granted new drug product exclusivitytoEvoke Pharma Inc's(NASDAQ: EVOK) Gimoti (metoclopramide) ...

Evoke Pharma Granted FDA Market Exclusivity for GIMOTI®
26 Apr, 2022 Yahoo! Finance

Reinforces Company’s Robust Intellectual Property PortfolioSOLANA BEACH, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced that it has been granted new drug product exclusivity by the U.S. Food and Drug Administration (FDA) for GIMOTI (metoclopramide) nasal spray. Evoke now has exclusive marketing rights over a period of three (3) years from the origi

54 Biggest Movers From Yesterday
20 Apr, 2022 FinancialContent

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron ...

Evoke Pharma Announces Approval of GIMOTI® to the Texas Medicaid Preferred Drug List
19 Apr, 2022 Yahoo! Finance

Market access improves with approximately 5 million people in the Texas Medicaid patient networkSOLANA BEACH, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, announced today that GIMOTI® (metoclopramide) nasal spray a novel treatment solution for the treatment of symptoms associated with diabetic gastroparesis (DGP), has been added to the Texas Medicaid Preferred D

12 Health Care Stocks Moving In Thursday's After-Market Session
14 Apr, 2022 FinancialContent

Gainers Kaleido Biosciences (NASDAQ:KLDO) stock increased by 10.3% to $0.32 during Thursday's after-market session. Today's trading ...

Evoke Pharma, Inc (EVOK) is a NASDAQ Common Stock listed in , ,

970x250